Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

48.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Damage Monitoring and Localization Imaging of Aluminum Alloy Thin-Walled Structure Based on Remote Bonding Fiber Bragg Gratings Sensing.

Materials (Basel, Switzerland)·2024
Same author

Molecular bases of morphologically diffused tumors across multiple cancer types.

National science review·2022
Same author

Brain metastases: It takes two factors for a primary cancer to metastasize to brain.

Frontiers in oncology·2022
Same author

Two-dimensional plasma density evolution local to the inversion layer during sawtooth crash events using beam emission spectroscopy.

The Review of scientific instruments·2022
Same author

Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.

PloS one·2019
Same author

Annotating Early Esophageal Cancers Based on Two Saliency Levels of Gastroscopic Images.

Journal of medical systems·2018

Related Experiment Video

Updated: Jun 24, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.9K

Diffuse tumors: Molecular determinants shared by different cancer types.

Xuan Li1, Dingyun Liu2, Zhipeng Wu2

  • 1Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, 130012, China; School of Medicine, Southern University of Science and Technology, Shenzhen, China.

Computers in Biology and Medicine
|June 8, 2024
PubMed
Summary

This study reveals that (poly-)sialic acids influence cancer morphology and aggressiveness. Specific poly-sialic acids synthesized by ST8SIA4 impact immune activity, while circulating growth factors explain why diffuse cancers affect younger patients.

Keywords:
Cancer malignancyCancer morphologyCancer occurrence riskCirculating growth factorsSialic acid

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.5K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Related Experiment Videos

Last Updated: Jun 24, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.9K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.5K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Area of Science:

  • Computational biology
  • Cancer research
  • Molecular oncology

Background:

  • Cancer exhibits diverse subtypes, including diffuse and non-diffuse, with distinct morphologies and aggressiveness.
  • The underlying molecular drivers for these subtype distinctions remain largely unidentified.

Purpose of the Study:

  • To investigate the molecular determinants of diffuse vs. non-diffuse cancer morphology and aggressiveness.
  • To elucidate the reasons behind differential immunoactivity and patient age distribution in diffuse cancers.
  • To identify key molecular factors driving cancer subtype formation and progression.

Main Methods:

  • Utilized transcriptomic data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.
  • Applied a computational framework for analyzing cancer drivers.
  • Correlated findings with existing experimental studies across multiple cancer types.

Main Results:

  • Identified (poly-)sialic acid levels on cancer cells as a key factor in morphology and aggressiveness.
  • Determined that ST8SIA4-synthesized poly-sialic acids are crucial for distinct immunoactivities.
  • Found that specific circulating growth factors dictate the predilection of diffuse cancers in younger patients.

Conclusions:

  • The level of (poly-)sialic acids is a significant determinant of cancer subtype morphology and aggressiveness.
  • ST8SIA4-synthesized poly-sialic acids play a critical role in cancer-specific immune responses.
  • Circulating growth factors explain the association between diffuse cancer subtypes and younger patient demographics.
  • These findings are generalizable across various cancer types, including breast, prostate, lung, liver, and thyroid cancers.